KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Work In Process (2018 - 2025)

ClearPoint Neuro's Work In Process history spans 12 years, with the latest figure at $5.7 million for Q1 2025.

  • For Q1 2025, Work In Process changed N/A year-over-year to $5.7 million; the TTM value through Mar 2025 reached $5.7 million, changed N/A, while the annual FY2024 figure was $5.5 million, 14.89% down from the prior year.
  • Work In Process for Q1 2025 was $5.7 million at ClearPoint Neuro, up from $5.5 million in the prior quarter.
  • Across five years, Work In Process topped out at $6.5 million in Q4 2023 and bottomed at $1.6 million in Q1 2021.
  • The 4-year median for Work In Process is $3.9 million (2021), against an average of $3.9 million.
  • The largest annual shift saw Work In Process soared 34.21% in 2021 before it decreased 14.89% in 2024.
  • A 4-year view of Work In Process shows it stood at $2.3 million in 2021, then soared by 179.43% to $6.5 million in 2023, then fell by 14.89% to $5.5 million in 2024, then rose by 2.73% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Work In Process are $5.7 million (Q1 2025), $5.5 million (Q4 2024), and $6.5 million (Q4 2023).